Sign in

Private company

Centogene N.V.

Medical laboratories services company1

In its 2024 annual report (Form 20-F) the company says: “Centogene N.V. is a Dutch public company ( naamloze vennootschap ) organized under the laws of the Netherlands and our legal and commercial name is Centogene N.V.”4

Last updated Oct 21, 2026.

Overview

-35.5MNet income, fiscal 20232
  • IndustryServices-Medical Laboratories1
  • HeadquartersP71
  • Incorporated inNetherlands3
  • Business addressAm Strande 7, Rostock, 2M 180553
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

Centogene was founded by our former CEO, Prof. Arndt Rolfs, in 2006 in Rostock, Germany. In connection with our initial public offering (“IPO”), which closed on November 12, 2019, we executed a corporate reorganization whereby Centogene B.V., which was incorporated on October 11, 2018, was converted into Centogene N.V. and Centogene N.V. became the holding company for Centogene AG, which remains our principal operating subsidiary. Centogene N.V. is a Dutch public company ( naamloze vennootschap ) organized under the laws of the Netherlands and our legal and commercial name is Centogene N.V.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-$31.8MFree cash flow2

Financial statements

Gross profit56782$17.2M in 2023+3% since 2017
0$10.0M$20.0M$30.0M2017: $16.8M$16.8M20172018: $20.5M$20.5M2018+23%2019: $22.8M$22.8M2019+11%2020: $3.2M$3.2M2020−86%2021: $13.5M$13.5M2021+326%2022: $19.8M$19.8M2022+46%2023: $17.2M$17.2M2023−13%
Operating income56782-$29.7M in 2023+566% since 2017
-$60.0M-$40.0M-$20.0M02017: -$4.5M-$4.5M20172018: -$10.6M-$10.6M2018+138%2019: -$18.7M-$18.7M2019+76%2020: -$58.4M-$58.4M2020+213%2021: -$56.6M-$56.6M2021−3%2022: -$36.8M-$36.8M2022−35%2023: -$29.7M-$29.7M2023−19%
Net income56782-$35.5M in 2023+549% since 2017
-$60.0M-$40.0M-$20.0M02017: -$5.5M-$5.5M20172018: -$11.3M-$11.3M2018+107%2019: -$20.9M-$20.9M2019+84%2020: -$22.0M-$22.0M2020+5%2021: -$46.2M-$46.2M2021+110%2022: -$31.8M-$31.8M2022−31%2023: -$35.5M-$35.5M2023+12%
Fiscal year20162017201820192020202120222023
Cost of revenue28.7M EUR227.7M EUR231.3M EUR2
Gross profit16.8M EUR520.5M EUR622.8M EUR73.2M EUR813.5M EUR219.8M EUR217.2M EUR2
Research and development19.3M EUR217.5M EUR212.4M EUR2
Operating income-4.5M EUR5-10.6M EUR6-18.7M EUR7-58.4M EUR8-56.6M EUR2-36.8M EUR2-29.7M EUR2
Interest802.0K EUR24.9M EUR28.4M EUR2
Income before tax-57.4M EUR2-38.6M EUR2-35.2M EUR2
Income tax-70.0K EUR2107.0K EUR2287.0K EUR2
Net income-5.5M EUR5-11.3M EUR6-20.9M EUR7-22.0M EUR8-46.2M EUR2-31.8M EUR2-35.5M EUR2
Earnings per share-1 EUR/shares7-1 EUR/shares8-2 EUR/shares2-1 EUR/shares2-1 EUR/shares2
Earnings per share (diluted)-1 EUR/shares7-1 EUR/shares8-2 EUR/shares2-1 EUR/shares2-1 EUR/shares2
Shares (weighted, basic)22.4M shares226.8M shares228.2M shares2
Shares (weighted, diluted)22.4M shares7

Compare Centogene N.V. with another company

Corporate structure

Centogene N.V. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Centogene N.V.

  • Centogene N.V. P7

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Centogene N.V. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net5.6M EUR2 Dec 31, 20236.8M EUR2 Dec 31, 2022−17.1%
Operating-lease assets (leased space)13.6M EUR2 Dec 31, 202315.4M EUR2 Dec 31, 2022−11.2%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents19.1M EUR2 Dec 31, 202336.0M EUR2 Dec 31, 2022−46.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)6.8M EUR2 Dec 31, 20237.4M EUR2 Dec 31, 2022−7.4%

Inventory

ItemLatestA year beforeChange
Inventory, total2.5M EUR2 Dec 31, 20231.8M EUR2 Dec 31, 2022+35.4%
Raw materials2.3M EUR2 Dec 31, 20231.8M EUR2 Dec 31, 2022+25.9%

Former names

  • Centogene B.V.Oct 31, 2018 to Nov 8, 20193

Filings

111 filings to the SEC since October 2021: 3 annual reports, 4 large holders, 104 other. The latest 20:

  1. Jan 10, 20256-K EDGAR
  2. Dec 5, 20246-K EDGAR
  3. Nov 19, 20246-K EDGAR
  4. Nov 13, 20246-K EDGAR
  5. Nov 6, 2024SC 13G EDGAR
  6. Oct 30, 20246-K EDGAR
  7. Oct 16, 20246-K EDGAR
  8. Oct 11, 20246-K EDGAR
  9. Oct 1, 20246-K EDGAR
  10. Sep 26, 20246-K/A EDGAR
  11. Sep 25, 20246-K EDGAR
  12. Sep 19, 20246-K EDGAR
  13. Sep 6, 20246-K EDGAR
  14. Aug 20, 20246-K EDGAR
  15. Aug 8, 20246-K EDGAR
  16. Aug 1, 20246-K EDGAR
  17. Jun 20, 20246-K EDGAR
  18. May 31, 20246-K EDGAR
  19. May 29, 20246-K EDGAR
  20. May 17, 2024IRANNOTICE EDGAR

The 111 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Centogene N.V. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCentogene N.V.1
  • CIK0001757097
  • Filer statusNon-accelerated filer<br>emerging growth company1
  • Incorporated inNetherlands1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8071 Services-Medical Laboratories1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressAm Strande 7, Rostock, 2M 180551
  • Phone49 30 2130 003251
  • Shares outstanding27,595,835 as of Dec 31, 20232
  • On EDGAR sinceOct 31, 20181
  • Filings201 in all: 6-K (142), CORRESP (7), SC 13D/A (6), 20-F (5), IRANNOTICE (5), UPLOAD (5), 144 (3), DRSLTR (3)1
    All 23 form types

    SC 13D (3), SC 13G (3), 424B4 (2), DRS (2), DRS/A (2), EFFECT (2), F-1 (2), NT 20-F (2), 25-NSE (1), 6-K/A (1), 8-A12B (1), CERT (1), F-1/A (1), S-8 (1), SC 13G/A (1)

  • Latest filingsAnnual report (20-F) May 15, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11